Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama; Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama.
Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama; Center for Free Radical Biology, University of Alabama at Birmingham, Birmingham, Alabama.
Am J Pathol. 2020 May;190(5):947-957. doi: 10.1016/j.ajpath.2020.01.006. Epub 2020 Feb 18.
Monocyte rolling, adhesion, and transmigration across the endothelium are mediated by specific interactions between surface adhesion molecules. This process is fundamental to innate immunity and to inflammatory disease, including atherosclerosis, where monocyte egress into the intimal space is central to formation of fatty plaques. Monocytes are a heterogeneous population of three distinct subsets of cells, all of which play different roles in atherosclerosis progression. However, it is not well understood how interactions between different monocyte subsets and the endothelium are regulated. Furthermore, it is appreciated that endothelial adhesion molecules are heavily N-glycosylated, but beyond regulating protein trafficking to the cell surface, whether and if so how these N-glycans contribute to monocyte recruitment is not known. This review discusses how changes in endothelial N-glycosylation may impact vascular and monocytic inflammation. It will also discuss how regulating N-glycoforms on the endothelial surface may allow for the recruitment of specific monocyte subsets to sites of inflammation, and how further understanding in this area may lead to the development of glyco-specific therapeutics in the treatment of cardiovascular disease.
单核细胞在内皮细胞上的滚动、黏附和迁移是由表面黏附分子之间的特异性相互作用介导的。这个过程是先天免疫和炎症性疾病的基础,包括动脉粥样硬化,其中单核细胞渗出到内膜空间是形成脂肪斑块的核心。单核细胞是一个异质群体,由三个不同的细胞亚群组成,所有这些亚群在动脉粥样硬化进展中都发挥着不同的作用。然而,目前还不清楚不同单核细胞亚群与内皮细胞之间的相互作用是如何调节的。此外,人们已经认识到内皮细胞黏附分子高度糖基化,但除了调节蛋白质向细胞表面的运输外,这些 N-聚糖是否以及如何有助于单核细胞的募集尚不清楚。这篇综述讨论了内皮细胞 N-糖基化的变化如何影响血管和单核细胞炎症。它还将讨论调节内皮表面的 N-糖型如何允许特定的单核细胞亚群募集到炎症部位,以及在这一领域的进一步理解如何导致针对心血管疾病的糖特异性治疗药物的开发。